Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin

mTOR Signaling in Growth Control and Disease

(2012) Mathieu Laplante et al.   CELL

Interleukin-1β Interferes with Epidermal Homeostasis through Induction of Insulin Resistance: Implications for Psoriasis Pathogenesis

(2012) Claudia Buerger et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity

(2011) Wolf-Henning Boehncke et al.   EXPERIMENTAL DERMATOLOGY

Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes

(2010) Jiawei Zhao et al.   MOLECULAR IMMUNOLOGY

The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin

(2009) R.B. Kjellerup et al.   BRITISH JOURNAL OF DERMATOLOGY

Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2

(2009) S-J. Chen et al.   BRITISH JOURNAL OF DERMATOLOGY

Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget’s disease

(2009) S. Chen et al.   BRITISH JOURNAL OF DERMATOLOGY

TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2

(2009) J. Copp et al.   CANCER RESEARCH

Psoriasis

(2009) Frank O. Nestle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reactive Oxygen Species in Tumor Necrosis Factor-α-Activated Primary Human Keratinocytes: Implications for Psoriasis and Inflammatory Skin Disease

(2008) Chen N. Young et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY